342 research outputs found

    Dengue Diagnostics: Current Scenario

    Get PDF
    There is an urgent requirement for specific, sensitive and inexpensive dengue diagnostic tools that can be used for clinical management, surveillance and outbreak investigations would permit early intervention to treat patients and prevent or control epidemics. Additionally, new techniques for the early detection of severe disease such as the use of biomarkers have the potential to decrease morbidity and mortality. Recent developments in rapid detection technologies offer the promise of improved diagnostics for case management and the early detection of dengue outbreaks. This short review summarizes the various diagnostics tests currently pursued

    A Mini-review of Dengue Vaccine Development

    Get PDF
    About 100 million dengue cases are reported annually and an estimated 2.5 billion people are susceptible to the infection mostly in the tropical regions. Dengue virus is a member of the Flavivirus genus and consists of four serotypes (DV-1, DV-2, DV-3, and DV- 4), each of which is capable of causing dengue fever and the more severe dengue hemorrhagic fever or dengue shock syndrome. There is an urgent need to develop a safe and effective vaccine that induces protective immune response to all the four serotypes overcoming antibody dependent enhancement. At present there is no licensed vaccine or specific therapeutic measures for prevention or management of the fatal infection. This mini review outlines the different vaccine candidates that are at various stages of development

    Targeting strategies and nanocarriers in vaccines and therapeutics

    Get PDF
    In the past few decades, remarkable advances have been made in the field of immunology and molecular biology. Even though the efficacy level, protein binding capacity and other pharmacological parameters are extraordinary, formulations have become more challenging in terms of making drugs or antigens reach specific sites of action, the release rate of a drug at the site of action, proper presentation of an antigen by antigen-presenting cells or dendritic cells and other pharmacokinetic and pharmacodynamic parameters of finished drug products and vaccines. The purpose of this review is to present a brief overview of the challenges to drug targeting, especially vaccines, as well as of different approaches designed to overcome these barriers

    Paraspeckles: nuclear bodies built on long noncoding RNA

    Get PDF
    Paraspeckles are ribonucleoprotein bodies found in the interchromatin space of mammalian cell nuclei. These structures play a role in regulating the expression of certain genes in differentiated cells by nuclear retention of RNA. The core paraspeckle proteins (PSF/SFPQ, P54NRB/NONO, and PSPC1 [paraspeckle protein 1]) are members of the DBHS (Drosophila melanogaster behavior, human splicing) family. These proteins, together with the long nonprotein-coding RNA NEAT1 (MEN-ϵ/β), associate to form paraspeckles and maintain their integrity. Given the large numbers of long noncoding transcripts currently being discovered through whole transcriptome analysis, paraspeckles may be a paradigm for a class of subnuclear bodies formed around long noncoding RNA
    corecore